What is the key factor in medical decisions?
Blood Tests
An accurate blood test depends on the quality of the specimen...
Current blood collection methods are antiquated and filled with human error leading to:
-Inaccurate test results
-Misdiagnosis
-Wrong treatments
-Repeat needle sticks
-Harmful patient care
-Increased hospital liability costs
-Death
A poor quality sample can be the result of:
The current blood collection method has two main factors resulting in poor sample quality: The element of human error, and vacuum technology is over half a century old. Human Errors: -Wrong patient identified and blood collected -Wrong patient label applied to collected patient's tube -Patient's tubes are mismatched for corresponding additive -Tubes collected in wrong order resulting in contaminated sample -Blood sample is not mixed immediately after draw -Blood sample is not thoroughly mixed for additive to prevent clotting -Sample is handled too roughly -Not enough blood is collected per tube Technology is Antiquated: -Existing tubes have excessive vacuum causing hemolysis -Excessive blood is needed per tube -There is no digital traceability in real time Assuring a good quality blood sample makes it to the lab is critical in providing physicians with the essential information to base medical decisions on. An estimated 60–70% of these decisions are based on laboratory test results. Regulatory agencies for medical laboratories exist to protect patient safety; these agencies have many regulations and guidelines in place for this purpose. Because these regulations are so numerous, human errors are prevalent.
Improve patient outcomes with automated blood sampling
Introducing AMVC
An automatic blood collection system that obtains superior samples using enforced compliance while reducing liability risk
Improved specimens = Improved results =
Improved patient care
AMVC stands for Automated Micro Venus Collection System. Utilizing a generic collection vessel, hospital phlebotomy is streamlined with an on-demand handheld electronic device, elevating the traditional needle stick blood draw. This system is focused on enhanced patient safety through forced compliance in blood collection procedures.
The AMVC System decreases providers costs and liability associated risks by diminishing the need for repeat sample collection. The patient's medical data is documented by the system. Electronically capturing all steps and information, from the initial request for sample, throughout the blood collection process, to lab results.
How Innovation Impacts the quality of Health Care
The AMVC
Digital Device
The handheld unit is the central link between the hospital information system and the successful controlled completion of the specimen sampling and ensures regulatory compliance along every step of the way.
The digital nature of the device allows for positive patient identification, correct orders and specimen requirements from hospital software via automatic download, and is compatible with all current blood collection sets, wing sets, venous access devices, IV lines, luerlocks, etc. Thus improving overall hospital workflow.
Improved Specimen Quality for Testing
The handheld device works with a generic collection tube that minimizes the amount of blood collected, thereby meeting regulatory and medical association mandates.
Precise amounts of additive is introduced to each tube on demand, AMVC's streamlined technology, gently integrates additive into the sample. Creating a customized point of care sample, appropriate for all patient types including pediatric and geriatric.
Labeled Automatically During Collection
Before the specimen tube is released from the device the sample is labeled with patient information reducing risk liability.
Existing Laboratory Equipment
AMVC specimen samples integrate into existing hospital equipment for analysis for a seamless transition away from standard vacuum tubes.
Improved Patient Care
The AMVC System engineers out human errors that result in regulatory compliance failures (avoiding remediation impacts and increased liability), wrong patient results and repeat testing leading to delayed treatments and additional hospital stays. (Estimated U.S. annual cost due to retesting alone- $37 billion)
Federal government has regulatory requirements set up to protect patient safety – if a hospital doesn’t meet those requirements, they risk loosing government funding (Medicare/Medicaid and therefore insurance payments)